What was Dermisonics’s price range in the past 12 months?
Dermisonics lowest stock price was $0.01 and its highest was $0.01 in the past 12 months.
What is Dermisonics’s market cap?
Dermisonics’s market cap is $831.
When is Dermisonics’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
Is Dermisonics overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Dermisonics pay dividends?
Dermisonics does not currently pay dividends.
What is Dermisonics’s EPS estimate?
Dermisonics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Dermisonics have?
Dermisonics has 63,909,000 shares outstanding.
Which hedge fund is a major shareholder of Dermisonics?
Currently, no hedge funds are holding shares in DMSI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Dermisonics
Dermisonics, Inc. develops and produces ultrasonic technologies and equipment for the transdermal administration of medications. A core focus for the company is the creation, evaluation, and market launch of its unique active transdermal patch, known as the U-Strip. This innovative patch is designed to facilitate the needle-free entry of large molecular weight drugs, like Insulin, directly into the circulatory system. The firm was originally incorporated as Second Stage Ventures, Inc. before adopting its current name, Dermisonics, Inc., in October 2004. Founded in 2000, the company maintains its principal offices in Irvine, California.